Merck KGaA Quarterly Profit Beats Estimates; Forecast RaisedBy and
Profit from healthcare unit climbed 16 percent in quarter
Sales and earnings in 2016 may be higher than earlier forecast
Merck KGaA reported second-quarter profit that beat analysts’ estimates as the prescription-drug division’s earnings climbed, prompting the German company to raise its forecast for the full year.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.